MIST Milestone Pharmaceuticals Inc. - Common Shares
$1,09
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$1–$3
4% of range
Analystenbewertung
BUY
12 analysts
Kursziel
$6
+481% upside
P/E (TTM)
-1.6
ROE
-525.0%
Nettogewinnmarge
—
MIST Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.09
Marktkapitalisierung
$128M
P/E (TTM)
-1.6
EPS (TTM)
$-0.75
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-525.0%
Verschuldungsgrad
—
52W-Spanne
$1 – $3
MIST Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-0.75
2020-12-31
→
2025-12-31
Freier Cashflow
$-49M
2019-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MIST
Peer-Median
P/E (TTM)
-1.6
—
P/B (K/B)
3.1
0.5
Price / FCF (Kurs / FCF)
-2.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MIST
Peer-Median
ROA
-66.7%
-73.1%
ROE
-525.0%
-92.8%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MIST
Peer-Median
Current Ratio (Liquiditätsgrad)
8.0
4.8
Quick Ratio
7.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MIST
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MIST
Peer-Median
MIST Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
12 Analysten
- Starker Kauf 3 25,0%
- Kauf 7 58,3%
- Halten 2 16,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
6 Analysten · 2026-08-17
Median
$7.00
Mittelwert
$6.33
← Unter allen Zielen
$1.09
Tief
$2.00
Hoch
$8.00
Median-Ziel
$7.00
+542,1%
Mittelwert-Ziel
$6.33
+480,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.10%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.21 | $-0.20 | -0.01% |
| 31. März 2026 | $-0.20 | $0.31 | -0.51% |
| 31. Dezember 2025 | $-0.18 | $-0.16 | -0.02% |
| 30. September 2025 | $-0.12 | $-0.17 | 0.05% |
| 30. Juni 2025 | $-0.20 | $-0.18 | -0.02% |
| 31. März 2025 | $-0.31 | $-0.19 | -0.12% |
| 31. Dezember 2024 | $-0.20 | $-0.16 | -0.04% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $14M | $31M | $40M | $39M | $34M | $42M | $17M | |
| SG&A Expense | $17M | $17M | $16M | $16M | $12M | $10M | $7M | $3M | |
| Operating Income | $-62M | $-42M | $-61M | $-60M | $-43M | $-51M | $-58M | $-24M | |
| Interest Expense | · | · | $3M | · | · | · | · | · | |
| Interest Income | $3M | $4M | $4M | · | · | · | · | · | |
| Pretax Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| Income Tax | · | · | · | · | · | $-17.0K | $-56.0K | $74.0K | |
| Net Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| EPS (Basic) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EPS (Diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EBITDA | $-62M | $-42M | · | · | $-43M | $-51M | $-58M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $25M | $14M | $8M | $114M | $72M | $120M | $86M | |
| Short-term Investments | $33M | $44M | $52M | $57M | $0 | $70M | · | $29.0K | |
| Inventory | $648.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $6M | $4M | $5M | $2M | $1M | |
| Current Assets | $112M | $74M | $73M | $72M | $119M | $149M | $122M | $88M | |
| PP&E (Net) | $511.0K | $197.0K | $277.0K | $257.0K | $215.0K | $308.0K | $405.0K | $30.0K | |
| PP&E (Gross) | $917.0K | $488.0K | $468.0K | $377.0K | $454.0K | $454.0K | $454.0K | $41.0K | |
| Accum. Depreciation | $406.0K | $291.0K | $191.0K | $120.0K | $239.0K | $146.0K | $49.0K | $11.0K | |
| Total Assets | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Accounts Payable | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $4M | |
| Accrued Liabilities | $8M | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $8M | $7M | $6M | $7M | $6M | $8M | $5M | |
| Capital Leases | $539.0K | $874.0K | $1M | $2M | $474.0K | $696.0K | $184.0K | · | |
| Other Non-current Liabilities | $83.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $72M | $62M | $58M | $8M | $7M | $7M | $9M | $5M | |
| Long-term Debt | $57M | $53M | $50M | · | · | · | $0 | · | |
| Common Stock | $353M | $288M | $261M | $274M | $252M | $252M | $226M | $2M | |
| Paid-in Capital | $64M | $40M | $34M | $24M | $16M | $9M | $4M | $3M | |
| Retained Earnings | $-431M | $-368M | $-326M | $-266M | $-208M | $-163M | $-113M | $-58M | |
| Stockholders' Equity | $42M | $13M | $17M | $66M | $113M | $143M | $115M | $84M | |
| Liabilities + Equity | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Shares Outstanding | 106,236,344 | 53,353,984 | 33,483,111 | 34,286,002 | 29,897,559 | 29,827,997 | 24,505,748 | 596,787 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $105.0K | $92.0K | $89.0K | $93.0K | $97.0K | $38.0K | $10.0K | |
| Stock-based Comp | $7M | $6M | $10M | $9M | $7M | $5M | $1M | $633.0K | |
| Other Non-cash | $6M | $7M | · | · | $2M | $-6M | $3M | · | |
| Operating Cash Flow | $-49M | $-29M | $-46M | $-52M | $-33M | $-51M | $-51M | $-21M | |
| CapEx | $302.0K | $33.0K | $112.0K | $272.0K | · | · | $413.0K | $5.0K | |
| Investing Cash Flow | $11M | $8M | $5M | $-57M | $70M | $-70M | $-384.0K | $16M | |
| Stock Issued | $38M | $27M | · | $3M | · | $25M | · | · | |
| Net Stock Activity | $38M | $27M | · | · | · | $25M | · | · | |
| Financing Cash Flow | $86M | $32M | $48M | $3M | $5M | $73M | $85M | $80M | |
| Net Change in Cash | $48M | $12M | $6M | $-107M | $42M | $-48M | $34M | $75M | |
| Free Cash Flow | $-49M | $-29M | · | · | · | · | $-52M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.7% | -55.1% | · | · | -31.8% | -36.5% | -52.2% | · | |
| ROE | -525.0% | -223.5% | · | · | -35.7% | -40.7% | -44.6% | · | |
| ROIC | · | · | · | · | · | -35.4% | -50.3% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.1 | · | · | 17.6 | 24.1 | 14.7 | · | |
| Quick Ratio | 7.6 | 8.6 | · | · | 16.8 | 23.1 | 14.4 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | · | |
| Market Cap | $215M | $126M | · | · | $196M | $200M | $392M | · | |
| P/E | -2.7 | -3.5 | -1.2 | -2.9 | -6.4 | -3.9 | · | · | |
| P/B | 5.1 | 9.6 | · | · | 1.7 | 1.4 | 3.4 | · | |
| P / Tangible Book | 5.1 | 9.6 | 3.3 | 2.0 | 1.7 | 1.4 | · | · | |
| P / Cash Flow | -4.4 | -4.4 | · | · | -5.9 | -3.9 | -7.7 | · | |
| P / FCF | -4.3 | -4.4 | · | · | · | · | -7.6 | · | |
| Earnings Yield | -37.1% | -28.4% | -83.2% | -34.8% | -15.6% | -25.4% | · | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Revenue | $559.0K | $238.0K | |
| Cost of Revenue | $32.0K | $14.0K | |
| R&D Expense | $4M | $3M | |
| SG&A Expense | $23M | $5M | |
| Operating Expenses | $26M | $24M | |
| Operating Income | $-26M | $-24M | |
| Interest Income | $2M | $2M | |
| Net Income | $-29M | $-26M | |
| EPS (Basic) | $-0.21 | $-0.20 | |
| EPS (Diluted) | $-0.21 | $-0.20 | |
| EBITDA | $-26M | $-24M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $170M | $71M | |
| Short-term Investments | $881.0K | $113M | |
| Receivables | $3M | $2M | |
| Inventory | $5M | $2M | |
| Prepaid Expense | $1M | $1M | |
| Current Assets | $180M | $192M | |
| PP&E (Net) | $469.0K | $500.0K | |
| Total Assets | $182M | $194M | |
| Accounts Payable | $8M | $10M | |
| Accrued Liabilities | $12M | $10M | |
| Current Liabilities | $22M | $21M | |
| Capital Leases | $192.0K | $366.0K | |
| Other Non-current Liabilities | $61.0K | $72.0K | |
| Total Liabilities | $163M | $158M | |
| Long-term Debt | $59M | $58M | |
| Common Stock | $385M | $374M | |
| Paid-in Capital | $63M | $63M | |
| Retained Earnings | $-485M | $-457M | |
| Stockholders' Equity | $18M | $36M | |
| Liabilities + Equity | $182M | $194M | |
| Shares Outstanding | 124,497,980 | 117,794,417 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| D&A | $57.0K | $56.0K | |
| Stock-based Comp | $1M | $1M | |
| Other Non-cash | · | $9M | |
| Operating Cash Flow | $-23M | $-16M | |
| CapEx | $26.0K | $45.0K | |
| Investing Cash Flow | $112M | $-80M | |
| Stock Issued | $0 | $11M | |
| Net Stock Activity | · | $11M | |
| Financing Cash Flow | $9M | $94M | |
| Net Change in Cash | $98M | $-2M | |
| Free Cash Flow | · | $-16M |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Operating Margin | -4585.0% | -9942.4% | |
| Net Margin | -5118.8% | -10952.1% | |
| EBITDA Margin | -4585.0% | -9918.9% | |
| ROA | -25.0% | -20.4% | |
| ROE | -12098.9% | -174.2% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 8.1 | 9.2 | |
| Quick Ratio | 7.8 | 8.9 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | |
| Receivables Turnover | 0.4 | 0.3 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Net Income TTM | $-80M | $-72M | |
| Market Cap | $167M | $140M | |
| P/E | -1.8 | -1.4 | |
| P/B | 9.2 | 3.9 | |
| P / Tangible Book | 9.2 | 3.9 | |
| P / Cash Flow | · | -8.7 | |
| P / FCF | · | -8.7 | |
| Earnings Yield | -54.5% | -69.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-63M | $-42M | $-60M | $-58M | $-43M |
| Verwässerte EPS | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 8.0 | 9.1 | — | — | 17.6 |
| Quick Ratio | 7.6 | 8.6 | — | — | 16.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-49M | $-29M | — | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 90 Einreicher · $53.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 10 (-11 vs. Vorquartal) | 11 (-2 vs. Vorquartal) | 23 (+2 vs. Vorquartal) | 25 (+3 vs. Vorquartal) | +10.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $10.496.670 | 7.833.336 | 19,79% | Aktien |
| Propel Bio Management, LLC | $9.955.651 | 7.429.590 | 18,77% | Aktien |
| Point72 Asset Management, L.P. | $7.250.925 | 5.411.138 | 13,67% | Aktien |
| Simplify Asset Management Inc. | $4.488.168 | 3.349.379 | 8,46% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.210.573 | 3.142.219 | 7,94% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.733.620 | 2.040.015 | 5,15% | Aktien |
| Kalehua Capital Management LLC | $1.700.778 | 1.269.237 | 3,21% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.251.576 | 619.592 | 2,36% | Aktien |
| Lion Point Capital, LP | $1.098.800 | 820.000 | 2,07% | Aktien |
| TORONTO DOMINION BANK | $1.005.000 | 750.000 | 1,89% | Aktien |
| Boxer Capital Management, LLC | $893.332 | 666.666 | 1,68% | Aktien |
| AMERIPRISE FINANCIAL INC | $893.332 | 666.666 | 1,68% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $619.976 | 462.669 | 1,17% | Aktien |
| UBS Group AG | $554.345 | 413.690 | 1,05% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $482.259 | 359.895 | 0,91% | Aktien |
| AMH Equity Ltd | $463.342 | 231.671 | 0,87% | Aktien |
| GUARDIAN WEALTH ADVISORS, LLC / NC | $454.863 | 339.450 | 0,86% | Aktien |
| Aptus Capital Advisors, LLC | $454.863 | 339.450 | 0,86% | Aktien |
| Seven Fleet Capital Management LP | $362.112 | 270.233 | 0,68% | Aktien |
| Squarepoint Ops LLC | $310.644 | 231.824 | 0,59% | Aktien |
| LPL Financial LLC | $295.970 | 220.873 | 0,56% | Aktien |
| Balyasny Asset Management L.P. | $295.467 | 220.498 | 0,56% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $232.763 | 173.704 | 0,44% | Aktien |
| CITADEL ADVISORS LLC | $220.162 | 164.300 | 0,42% | Verkaufsoption |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | $201.000 | 150.000 | 0,38% | Aktien |
| Wealthspire Advisors, LLC | $188.443 | 140.629 | 0,36% | Aktien |
| Valeo Financial Advisors, LLC | $175.137 | 130.699 | 0,33% | Aktien |
| ADAR1 Capital Management, LLC | $134.000 | 100.000 | 0,25% | Aktien |
| Cascades Capital Asset Management, LLC | $112.037 | 83.610 | 0,21% | Aktien |
| Quadrature Capital Ltd | $86.646 | 64.661 | 0,16% | Aktien |
| JANE STREET GROUP, LLC | $77.435 | 57.787 | 0,15% | Aktien |
| CITADEL ADVISORS LLC | $75.174 | 56.100 | 0,14% | Kaufoption |
| SIMPLEX TRADING, LLC | $72.589 | 54.171 | 0,14% | Aktien |
| Bay Rivers Group | $62.488 | 46.633 | 0,12% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $54.657 | 40.789 | 0,10% | Aktien |
| October Effect Ltd | $53.600 | 40.000 | 0,10% | Aktien |
| Focus Partners Wealth | $48.240 | 36.000 | 0,09% | Aktien |
| MORGAN STANLEY | $42.244 | 31.525 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $42.138 | 31.446 | 0,08% | Aktien |
| JANE STREET GROUP, LLC | $41.808 | 31.200 | 0,08% | Verkaufsoption |
| Mariner, LLC | $37.192 | 27.830 | 0,07% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $35.644 | 26.600 | 0,07% | Aktien |
| XTX Topco Ltd | $35.265 | 26.317 | 0,07% | Aktien |
| MARSHALL WACE, LLP | $34.335 | 25.623 | 0,06% | Aktien |
| Welch & Forbes LLC | $33.500 | 25.000 | 0,06% | Aktien |
| Tower Research Capital LLC (TRC) | $32.408 | 24.185 | 0,06% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $31.490 | 23.500 | 0,06% | Aktien |
| Exit Wealth Advisors, LLC. | $30.407 | 22.692 | 0,06% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.284 | 22.600 | 0,06% | Verkaufsoption |
| STATE STREET CORP | $30.236 | 22.564 | 0,06% | Aktien |
| Stephenson & Company, Inc. | $26.800 | 20.000 | 0,05% | Aktien |
| Taylor Financial Group, Inc. | $26.800 | 20.000 | 0,05% | Aktien |
| HighTower Advisors, LLC | $26.800 | 20.000 | 0,05% | Aktien |
| JOURNEY STRATEGIC WEALTH LLC | $23.800 | 20.000 | 0,04% | Aktien |
| Federation des caisses Desjardins du Quebec | $22.487 | 16.781 | 0,04% | Aktien |
| TWO SIGMA SECURITIES, LLC | $22.438 | 16.745 | 0,04% | Aktien |
| Cetera Investment Advisers | $21.933 | 16.368 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $21.440 | 16.000 | 0,04% | Kaufoption |
| Pathstone Holdings, LLC | $20.770 | 15.500 | 0,04% | Aktien |
| AE Wealth Management LLC | $20.100 | 15.000 | 0,04% | Aktien |
| Vision Retirement, LLC | $20.100 | 15.000 | 0,04% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $19.840 | 16.000 | 0,04% | Aktien |
| EARNED WEALTH ADVISORS, LLC | $19.773 | 14.756 | 0,04% | Aktien |
| Bronte Capital Management Pty Ltd. | $19.283 | 14.390 | 0,04% | Aktien |
| WINTON GROUP Ltd | $19.162 | 14.300 | 0,04% | Aktien |
| Beta Wealth Group, Inc. | $18.930 | 14.127 | 0,04% | Aktien |
| Strategic Family Wealth Counselors, L.L.C. | $18.593 | 13.875 | 0,04% | Aktien |
| Creative Planning | $17.527 | 13.080 | 0,03% | Aktien |
| Rockefeller Capital Management L.P. | $16.750 | 12.500 | 0,03% | Aktien |
| Safeguard Investment Advisory Group, LLC | $16.624 | 12.406 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.482 | 12.300 | 0,03% | Kaufoption |
| Eaton Financial Holdings Company, LLC | $13.735 | 10.250 | 0,03% | Aktien |
| INTEGRAL INVESTMENT ADVISORS, INC. | $13.400 | 10.000 | 0,03% | Aktien |
| Secure Asset Management, LLC | $13.400 | 10.000 | 0,03% | Aktien |
| CWM, LLC | $11.900 | 10.000 | 0,02% | Aktien |
| ROYAL BANK OF CANADA | $9.000 | 6.458 | 0,02% | Aktien |
| US BANCORP \DE\ | $4.288 | 3.200 | 0,01% | Aktien |
| Arax Advisory Partners | $4.090 | 3.053 | 0,01% | Aktien |
| PNC Financial Services Group, Inc. | $3.752 | 2.800 | 0,01% | Aktien |
| Aptus Capital Advisors, LLC | $670 | 500 | 0,00% | Kaufoption |
| Medallion Wealth Advisors, LLC | $456 | 340 | 0,00% | Aktien |
| Rialto Wealth Management, LLC | $402 | 300 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $300 | 224 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $165 | 123 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $126 | 94 | 0,00% | Aktien |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $80 | 100 | 0,00% | Aktien |
| SG Americas Securities, LLC | $61 | 45.574 | 0,00% | Aktien |
| Cambridge Investment Research Advisors, Inc. | $18 | 13.480 | 0,00% | Aktien |
| Virtu Financial LLC | $16 | 11.613 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $8 | 6 | 0,00% | Aktien |
Unternehmensinsider 22 Insider · 8 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joseph Oliveto | President and CEO | 16. Februar 2023 A | 280.555 | 0 | 0 | $0 |
| Amit Hasija | CFO & EVP of Corp. Development | 16. Februar 2023 A | — | 0 | 0 | $0 |
| Jeffrey Edward Nelson | Chief Operating Officer | 16. Februar 2023 A | — | 0 | 0 | $0 |
| David Bharucha | Chief Medical Officer | 16. Februar 2023 A | 10.000 | 0 | 0 | $0 |
| Lorenz Muller | Chief Commercial Officer | 16. Februar 2023 A | 108.386 | 0 | 0 | $0 |
| Francis Plat | Chief Medical Officer | 24. März 2021 A | — | 0 | 0 | $0 |
| Timothy Maness | Chief Accounting Officer | 9. September 2019 A | — | 0 | 0 | $0 |
| Philippe Douville | Chief Scientific Officer | 13. Mai 2019 C | 43.392 | 0 | 0 | $0 |
| Stuart Duty | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Robert James Wills | Direktor | 10. Juni 2026 A | 15.000 | 0 | 0 | $0 |
| Andrew Saik | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Seth H. Z. Fischer | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Michael John Tomsicek | Direktor | 10. Juni 2026 A | 15.000 | 0 | 0 | $0 |
| Lisa M. Giles | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Joseph C Papa | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Richard C Pasternak | Direktor | 7. Juni 2023 A | 10.000 | 0 | 0 | $0 |
| Debra K. Liebert | Direktor | 7. Juni 2023 A | 4.000 | 0 | 0 | $0 |
| Paul F Truex | Direktor | 31. Mai 2022 M | 81.780 | 0 | 0 | $0 |
| Paul R Edick | Direktor | 5. Juni 2020 A | — | 0 | 0 | $0 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10%-Eigentümer | 29. Juli 2020 S | 2.254.920 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 25. November 2019 S | 2.434.470 | 0 | 0 | $0 |
| BDC CAPITAL INC. | 10%-Eigentümer | 8. Mai 2019 P | 2.388.088 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Alta Fundamental Advisers LLC, Gilbert Li, Jeremy Carton ×2 Einreichungen | 16. Juli 2024 | — | Erste Einreichung | Vorstandskampagne | SEC |
| Novo Holdings A/S ×6 Einreichungen | 24. Oktober 2022 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.